Patent · US Active

Methods of treatment of endobronchial infections

US8664187B2 · kind B2 · utility

1Cited by
19References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 24, 2012
Grant dateMar 4, 2014
Priority date
Expiry dateFeb 24, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.